跳至主要内容
临床试验/TCTR20220407005
TCTR20220407005已完成4 期

The optimal dose of dexmedetomidine for reduce the postoperative catheter related bladder discomfort in post-anesthesia care unit

The Quzhou Affiliated Hospital of Wenzhou Medical University0 个研究点目标入组 29 人开始时间: 2022年4月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • American Society of Anesthesiologists (ASA) I-II
  • patients between 18 and 80 years in the PACU after general anesthesia
  • diagnosed Catheter-related bladder discomfort

排除标准

  • Patients with a history of bladder outflow obstruction, urinary tract infection, neurogenic blad-der, chronic analgesic abuse, severe hepatic or renal disease, arrhythmia, and morbid obesity were excluded from this trial.

研究者

发起方
The Quzhou Affiliated Hospital of Wenzhou Medical University

相似试验